WebMD: The science of horror response
UC expert explains how hormones affect reaction to scary movies
It's Halloween season, where horror lovers flock to haunted houses and watch scary movies while the scaredy cats try to avoid all things spooky.
But what are the underlying reasons that determine whether you love the thrill of feeling scared or hate it?
Shana Feibel, assistant professor of clinical psychiatry & behavioral neuroscience in the College of Medicine and a psychiatrist at the Lindner Center of Hope in Mason, said part of a person's response to being scared comes down to levels of hormones like epinephrine and oxytocin in the body.
"Epinephrine, also known as adrenaline, is secreted in the blood when someone is watching a scary film,” Feibel told WebMD. “It causes the sympathetic nervous system to take over and creates a feeling of fight or flight, which prepares the body to respond to a perceived threat.”
Watch the Fox19 morning show segment.
Featured photo at top courtesy of Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.